Al-Omari assumed his current position at Al Mana Medical Group in 2025. As of April 2026, the Saudi healthcare group operates with 7,000 employees serving over two million patients annually with a capacity of approximately 1,300 beds across eight facilities. In 2025, the group established specialized healthcare subsidiaries including Almana Pharma, Almana Care, OMNI Rad, and OmniLab. Al-Omari is a member of the Academic Advisory Boards at Prince Sattam Bin Abdulaziz University and Imam Muhammad bin Saud Islamic University's Faculty of Medicine.